Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Young Diane C., Directeur Médical. Officer active across 1 company, notably Celldex Therapeutics, Inc.. In total, 4 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €1.5m. History available since 12 November 2021. The latest transaction was disclosed on 11 June 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Diane C. Young is the Senior Vice President and Chief Medical Officer of Celldex Therapeutics, Inc. She oversees the company's medical initiatives, including product development and clinical research. Her role is essential in ensuring regulatory compliance and aligning medical strategies with business objectives.